Transient suppression of high-prevalence Kell blood group antigens and concomitant development of a Kell-related antibody that appears to recognize a high-prevalence Kell antigen not previously defined.

Autor: Titze TL; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway., Ulvahaug N; Transfusion Service, Vestfold Hospital, Tønsberg, Norway., Moksnes M; Cancer and Hematology Center, Vestfold Hospital, Tønsberg, Norway., Skeie N; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway., Crew VK; International Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, UK., Akkök ÇA; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway., Thornton N; International Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, UK.

Publikováno v: Immunohematology [Immunohematology] 2024 Dec 31; Vol. 40 (4), pp. 153-158. Date of Electronic Publication: 2024 Dec 31 (Print Publication: 2024).